Modeling Inherited Disorders of Post-Lanosterol Cholesterol Biosynthesis: From Animal Models to Patient-Derived Stem...

Area of Science:

• Biochemistry
• Genetics
• Developmental Biology

Background:

• Inherited cholesterol biosynthesis disorders result from impaired cholesterol synthesis, leading to sterol accumulation and various health issues.
• Pathogenesis involves cholesterol deficiency and toxic sterol intermediates, causing oxidative stress, developmental signaling disruption, and neurodevelopmental problems.

Purpose of the Study:

• To provide a comprehensive overview of experimental models for inherited cholesterol biosynthesis disorders.
• To critically discuss the strengths and limitations of various modeling systems.
• To highlight advancements in understanding disease mechanisms and therapeutic strategies.

Main Methods:

• Review of existing literature on experimental models for cholesterol biosynthesis disorders.
• Analysis of genetically engineered animal models, patient-derived cells, and induced pluripotent stem cell systems.
• Emphasis on Smith-Lemli-Opitz syndrome and other related disorders like desmosterolosis.

Main Results:

• Experimental models are crucial for elucidating disease mechanisms and evaluating therapies.
• Different models offer unique insights into sterol metabolism, developmental abnormalities, and cell-specific effects.
• Patient-derived and stem cell-based models show promise for personalized medicine.

Conclusions:

• A framework for selecting appropriate experimental models is presented.
• Future directions include patient-specific iPSC models and advanced multicellular systems.
• Continued research using diverse models is essential for developing effective treatments for these rare metabolic disorders.